These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22213326)

  • 1. Correlation of prostaglandin metabolizing enzymes and serum PGE2 levels with vitamin D receptor and serum 25(OH)2D3 levels in breast and ovarian cancer.
    Cordes T; Hoellen F; Dittmer C; Salehin D; Kümmel S; Friedrich M; Köster F; Becker S; Diedrich K; Thill M
    Anticancer Res; 2012 Jan; 32(1):351-7. PubMed ID: 22213326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
    Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
    Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
    Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients.
    Thill M; Fischer D; Kelling K; Hoellen F; Dittmer C; Hornemann A; Salehin D; Diedrich K; Friedrich M; Becker S
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):387-90. PubMed ID: 20304053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of calcitriol on prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cell lines.
    Thill M; Cordes T; Hoellen F; Becker S; Dittmer C; Kümmel S; Salehin D; Friedrich M; Diedrich K; Köster F
    Anticancer Res; 2012 Jan; 32(1):359-65. PubMed ID: 22213327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells.
    Thill M; Becker S; Fischer D; Cordes T; Hornemann A; Diedrich K; Salehin D; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3611-8. PubMed ID: 19667156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cells.
    Thill M; Hoellen F; Becker S; Dittmer C; Fischer D; Kümmel S; Salehin D; Friedrich M; Köster F; Diedrich K; Cordes T
    Anticancer Res; 2012 Jan; 32(1):367-72. PubMed ID: 22213328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
    Moreno J; Krishnan AV; Peehl DM; Feldman D
    Anticancer Res; 2006; 26(4A):2525-30. PubMed ID: 16886660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
    Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
    Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer.
    Silvagno F; Poma CB; Realmuto C; Ravarino N; Ramella A; Santoro N; D'Amelio P; Fuso L; Pescarmona G; Zola P
    Gynecol Oncol; 2010 Oct; 119(1):121-4. PubMed ID: 20599260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.
    Dai L; Perera DS; King DW; Southwell BR; Burcher E; Liu L
    J Pharmacol Exp Ther; 2012 Jan; 340(1):27-36. PubMed ID: 21957267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
    Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM
    Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.
    Moreno J; Krishnan AV; Swami S; Nonn L; Peehl DM; Feldman D
    Cancer Res; 2005 Sep; 65(17):7917-25. PubMed ID: 16140963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer.
    Ding Y; Tong M; Liu S; Moscow JA; Tai HH
    Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.